Nyxoah SA (NASDAQ:NYXH) Short Interest Up 29.0% in January

Nyxoah SA (NASDAQ:NYXH) saw a large increase in short interest during the month of January. As of January 30th, there was short interest totaling 288,814 shares, an increase of 29.0% from the January 15th total of 223,806 shares. Based on an average daily volume of 61,235 shares, the days-to-cover ratio is currently 4.7 days. Approximately 0.8% of the company’s stock are sold short. Approximately 0.8% of the company’s stock are sold short. Based on an average daily volume of 61,235 shares, the days-to-cover ratio is currently 4.7 days.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on NYXH. Stifel Nicolaus decreased their price objective on shares of Nyxoah from $12.00 to $11.00 and set a “buy” rating for the company in a report on Thursday, January 29th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Nyxoah in a research note on Monday, December 29th. Finally, Piper Sandler reissued an “overweight” rating and set a $9.00 price objective (down previously from $12.00) on shares of Nyxoah in a report on Friday, November 14th. Three analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $11.67.

Nyxoah Stock Up 1.4%

Nyxoah stock opened at $4.49 on Wednesday. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.70 and a quick ratio of 1.41. Nyxoah has a fifty-two week low of $4.10 and a fifty-two week high of $11.87. The firm has a fifty day moving average price of $4.77 and a two-hundred day moving average price of $5.28. The firm has a market cap of $152.93 million, a price-to-earnings ratio of -1.80 and a beta of 1.55.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Heights Capital Management Inc. acquired a new position in shares of Nyxoah during the fourth quarter worth approximately $3,575,000. Shay Capital LLC acquired a new position in Nyxoah during the 2nd quarter valued at $374,000. Kovack Advisors Inc. raised its stake in Nyxoah by 67.8% during the 3rd quarter. Kovack Advisors Inc. now owns 97,039 shares of the company’s stock valued at $446,000 after purchasing an additional 39,212 shares during the last quarter. Citadel Advisors LLC bought a new stake in Nyxoah in the 3rd quarter valued at $98,000. Finally, Rossmore Private Capital grew its position in Nyxoah by 12.6% in the 3rd quarter. Rossmore Private Capital now owns 132,746 shares of the company’s stock worth $616,000 after purchasing an additional 14,806 shares during the last quarter.

Nyxoah Company Profile

Nyxoah SA, headquartered in Mont-Saint-Guibert, Belgium, is a medical technology company focused on neuromodulation therapies for sleep‐disordered breathing. Established in 2018, the company’s primary offering is the Genio® system, a minimally invasive bilateral hypoglossal nerve stimulator designed to treat moderate to severe obstructive sleep apnea (OSA). By electrically stimulating the genioglossus muscle, the device helps maintain airway patency during sleep, reducing apnea events and improving overall sleep quality.

The Genio system comprises a small, implantable stimulator positioned submentally and an external activation unit worn by the patient.